Exosome-delivered pepDCBLD2 promotes glucose metabolism to induce chemoresistance in colon cancer
Oxaliplatin is a standard treatment for colon cancer, but chemoresistance is a considerable challenge. Dysregulation of circRNAs is involved in cancer and translatomics has found that some circRNAs encode polypeptides. Ribosome footprint profiling combined with circRNA sequencing was applied to screen circRNA with codi...